1. Home
  2. RNXT vs FTHM Comparison

RNXT vs FTHM Comparison

Compare RNXT & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • FTHM
  • Stock Information
  • Founded
  • RNXT 2012
  • FTHM 2010
  • Country
  • RNXT United States
  • FTHM United States
  • Employees
  • RNXT N/A
  • FTHM N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • FTHM Real Estate
  • Sector
  • RNXT Health Care
  • FTHM Finance
  • Exchange
  • RNXT Nasdaq
  • FTHM Nasdaq
  • Market Cap
  • RNXT 31.6M
  • FTHM 32.8M
  • IPO Year
  • RNXT 2021
  • FTHM 2020
  • Fundamental
  • Price
  • RNXT $1.04
  • FTHM $1.20
  • Analyst Decision
  • RNXT Strong Buy
  • FTHM Strong Buy
  • Analyst Count
  • RNXT 1
  • FTHM 4
  • Target Price
  • RNXT $9.00
  • FTHM $4.25
  • AVG Volume (30 Days)
  • RNXT 226.9K
  • FTHM 102.2K
  • Earning Date
  • RNXT 03-31-2025
  • FTHM 03-13-2025
  • Dividend Yield
  • RNXT N/A
  • FTHM N/A
  • EPS Growth
  • RNXT N/A
  • FTHM N/A
  • EPS
  • RNXT N/A
  • FTHM N/A
  • Revenue
  • RNXT N/A
  • FTHM $317,515,000.00
  • Revenue This Year
  • RNXT N/A
  • FTHM N/A
  • Revenue Next Year
  • RNXT N/A
  • FTHM $25.84
  • P/E Ratio
  • RNXT N/A
  • FTHM N/A
  • Revenue Growth
  • RNXT N/A
  • FTHM N/A
  • 52 Week Low
  • RNXT $0.77
  • FTHM $1.12
  • 52 Week High
  • RNXT $1.86
  • FTHM $3.37
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 32.70
  • FTHM 37.94
  • Support Level
  • RNXT $1.00
  • FTHM $1.12
  • Resistance Level
  • RNXT $1.18
  • FTHM $1.36
  • Average True Range (ATR)
  • RNXT 0.10
  • FTHM 0.09
  • MACD
  • RNXT -0.04
  • FTHM 0.01
  • Stochastic Oscillator
  • RNXT 8.00
  • FTHM 27.07

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.

Share on Social Networks: